A research team led by Dr. Dong-Zong Hung from China Medical University Hospital has developed a new cobra bite diagnostic strip using lateral flow immunoassay technology. The strip can rapidly detect cobra venom proteins with a detection limit of 5ng/mL. This diagnostic tool not only quickly diagnoses cobra bites but also tracks treatment efficacy, helping physicians assess the necessity and extent of debridement surgery.
Snake Bites Can Be Fatal! Rapid Diagnosis is Key to Saving Lives
Venomous snake bites are a significant global health issue, causing tens of thousands of deaths or disabilities annually. The World Health Organization has listed it as one of the neglected tropical diseases. In Taiwan, common venomous snake bites include those from cobras, green pit vipers, and Taiwan habu. Among these, cobra bites are the most severe, potentially leading to local tissue necrosis or even amputation if not treated promptly. Quick and accurate diagnosis is crucial for effective treatment of snake bites.
Traditional snake bite diagnosis methods primarily rely on clinical symptoms, physician experience, or patient identification, which can lead to misdiagnosis due to unclear or similar symptoms. Moreover, existing snake venom test kits are often limited to specific regional snakes and lack broad applicability.
New Diagnostic Strip: One Drop, 30 Minutes to Identify Snake Venom!
Dr. Hung points out that the breakthrough of the new cobra bite diagnostic strip lies in its diagnostic basis at the snake "genus" level rather than species-specific antibodies. This means the diagnostic strip can be applied to detect most Naja genus cobra venom proteins in Southeast Asia and Africa, offering extensive application potential. The strip is easy to use; a drop of the patient's blood or urine on the reagent can yield results within 30 minutes. When the local wound tissue fluid ICT-Cobra test turns negative, it indicates improvement in local necrosis, allowing patients to be discharged and followed up as outpatients. This technology is expected to significantly enhance the diagnosis and treatment efficiency of cobra bites while reducing medical costs.
The new cobra bite diagnostic strip offers the following advantages:
Rapid diagnosis: Completed within 30 minutes
High accuracy: Can differentiate between cobra and other venomous snake bites
Treatment efficacy tracking: Can assess local tissue necrosis status
Reduced medical costs: Can minimize misuse of anti-venom serum and delayed diagnosis
Wide Applicability, Enormous Potential Market Size
Dr. Hung states that the new cobra bite diagnostic strip is applicable not only in Taiwan but also in regions where cobras are found, such as Southeast Asia and Africa, with an estimated global potential market of $50 million. Multi-snake venom identification strips have already been developed, and customized snake venom rapid test designs and development will be offered in the future, aiming for broader application in venomous snake bite treatments worldwide.
Resource (mandarin)
